SB-751689

SB-751689 · GlaxoSmithKline

Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for SB-751689, covering 2008-10-13 to 2017-09-05. Get the full timeline:

Most recent: Clinical Trial Update: A Phase II Study Evaluating SB-751689 in Post-Menopausal Women With Osteoporosis. [Phase 2]